{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T19:25:15Z","timestamp":1773084315213,"version":"3.50.1"},"reference-count":93,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T00:00:00Z","timestamp":1083369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Laboratory and Clinical Medicine"],"published-print":{"date-parts":[[2004,5]]},"DOI":"10.1016\/j.lab.2004.02.002","type":"journal-article","created":{"date-parts":[[2004,5,12]],"date-time":"2004-05-12T10:25:58Z","timestamp":1084357558000},"page":"269-283","source":"Crossref","is-referenced-by-count":50,"title":["Clinical relevance of antimicrobial resistance in the management of pneumococcal community-acquired pneumonia"],"prefix":"10.1016","volume":"143","author":[{"given":"Charles","family":"Feldman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"suppl 1","key":"10.1016\/j.lab.2004.02.002_BIB1","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1086\/324524","article-title":"The continuing challenge of lower respiratory tract infections","volume":"34","author":"Moellering","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.lab.2004.02.002_BIB2","unstructured":"Pankey GA. Introduction. In: Ochsner clinic symposium on resistance and the use and misuse of antimicrobial therapy. Newton, Pa: Associates in Medical Marketing, 2000"},{"key":"10.1016\/j.lab.2004.02.002_BIB3","unstructured":"World Health Organization. WHO global strategy for containment of antimicrobial resistance. Available at: www.who.int\/emc\/amrpdfs\/WHO_Global_Strategy_English.pdf. Accessed April 4, 2004"},{"key":"10.1016\/j.lab.2004.02.002_BIB4","unstructured":"US Department of Health and Human Sciences. A USA public health action plan to combat antimicrobial resistance. Available at: www.cdc.gov\/drugresistance\/actionplan\/index\/htm. Accessed April 4, 2004"},{"key":"10.1016\/j.lab.2004.02.002_BIB5","unstructured":"Centers for Disease Control and Prevention. CDC\/National Center for Infectious Diseases website on antimicrobial resistance. Available at: www.cdc.gov\/drugresistance. Accessed April 4, 2004"},{"key":"10.1016\/j.lab.2004.02.002_BIB6","unstructured":"Schrag SJ, Beall B, Dowell S. Resistant pneumococcal infections: the burden of disease and challenges in monitoring and controlling antimicrobial resistance. Available at: www.who.int\/csr\/drugresist\/technicalguidance\/resistantinfection.pdf. Accessed April 4, 2004"},{"issue":"suppl 2","key":"10.1016\/j.lab.2004.02.002_BIB7","first-page":"12","article-title":"Surveillance of resistance in bacteria causing community-acquired respiratory tract infections","volume":"8","author":"Felmingham","year":"2002","journal-title":"CMI"},{"issue":"suppl A","key":"10.1016\/j.lab.2004.02.002_BIB8","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/S0954-6111(01)90022-8","article-title":"Clinical failures","volume":"95","author":"Garau","year":"2001","journal-title":"Respir Med"},{"key":"10.1016\/j.lab.2004.02.002_BIB9","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s00431-001-0907-3","article-title":"Pneumococcal disease in western Europe","volume":"161","author":"Cartwright","year":"2002","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.lab.2004.02.002_BIB10","doi-asserted-by":"crossref","first-page":"S236","DOI":"10.1046\/j.1532-5415.50.7s.4.x","article-title":"Resistant pathogens in respiratory tract infections in older people","volume":"50","author":"Bonomo","year":"2002","journal-title":"J Am Geriatr Soc"},{"issue":"suppl 3","key":"10.1016\/j.lab.2004.02.002_BIB11","first-page":"21","article-title":"Bacterial resistance","volume":"8","author":"Finch","year":"2002","journal-title":"CMI"},{"key":"10.1016\/j.lab.2004.02.002_BIB12","unstructured":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard (ed 6). NCCLS document M7-A6. Wayne, Pa: National Committee for Clinical Laboratory Standards, 2003"},{"key":"10.1016\/j.lab.2004.02.002_BIB13","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1001\/archinte.161.21.2538","article-title":"A fresh look at the definition of susceptibility of Streptococcus pneumoniae to \u03b2-lactam antibiotics","volume":"161","author":"Musher","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.lab.2004.02.002_BIB14","doi-asserted-by":"crossref","first-page":"759","DOI":"10.7326\/0003-4819-60-5-759","article-title":"Pneumococcal bacteremia, with special reference to bacteremic pneumococcal pneumonia","volume":"60","author":"Austrian","year":"1964","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.lab.2004.02.002_BIB15","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s11908-003-0078-7","article-title":"Drug-resistant Streptococcus pneumoniae in community-acquired pneumonia","volume":"5","author":"Henry","year":"2003","journal-title":"Curr Infect Dis Reports"},{"key":"10.1016\/j.lab.2004.02.002_BIB16","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1001\/jama.1996.03530260048030","article-title":"Prognosis and outcomes of patients with community-acquired-pneumonia. A meta-analysis","volume":"10","author":"Fine","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.lab.2004.02.002_BIB17","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2105\/AJPH.90.2.223","article-title":"Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997","volume":"90","author":"Feikin","year":"2000","journal-title":"Am J Public Health"},{"key":"10.1016\/j.lab.2004.02.002_BIB18","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1056\/NEJM199508243330802","article-title":"Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain","volume":"333","author":"Pallares","year":"1995","journal-title":"N Engl J Med"},{"issue":"suppl 2","key":"10.1016\/j.lab.2004.02.002_BIB19","first-page":"1","article-title":"Outcomes in lower respiratory tract infections and the impact of antimicrobial drug resistance","volume":"8","author":"Metlay","year":"2002","journal-title":"CMI"},{"issue":"suppl 36","key":"10.1016\/j.lab.2004.02.002_BIB20","doi-asserted-by":"crossref","first-page":"3s","DOI":"10.1183\/09031936.02.00400402","article-title":"Bacteriological evidence of antibiotic failure in pneumococcal lower respiratory tract infections","volume":"20","author":"Klugman","year":"2002","journal-title":"Eur Respir J"},{"key":"10.1016\/j.lab.2004.02.002_BIB21","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S0140-6736(67)92346-X","article-title":"A resistant pneumococcus","volume":"2","author":"Hansman","year":"1967","journal-title":"Lancet"},{"key":"10.1016\/j.lab.2004.02.002_BIB22","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/00001432-200104000-00011","article-title":"Streptococcus pneumoniae respiratory tract infections","volume":"14","author":"Klugman","year":"2001","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.lab.2004.02.002_BIB23","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1097\/00006454-199510000-00013","article-title":"Comparison of the response to antimicrobial therapy of penicillin-resistant and penicillin-susceptible pneumococcal disease","volume":"14","author":"Friedland","year":"1995","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.lab.2004.02.002_BIB24","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1542\/peds.102.6.1369","article-title":"Clinical characteristics and outcome of children with pneumonia attributable to penicillin-susceptible and penicillin-nonsusceptible Streptococcus pneumoniae","volume":"102","author":"Tan","year":"1998","journal-title":"Pediatrics"},{"key":"10.1016\/j.lab.2004.02.002_BIB25","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1086\/516340","article-title":"Clinical outcome of invasive infections by penicillin-resistant Streptococcus pneumoniae in Korean children","volume":"26","author":"Choi","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.lab.2004.02.002_BIB26","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1046\/j.1440-1843.2000.00227.x","article-title":"A comparative clinical study of pneumonia by penicillin-resistant and -sensitive Streptococcus pneumoniae in a community hospital","volume":"5","author":"Watanabe","year":"2000","journal-title":"Respirology"},{"key":"10.1016\/j.lab.2004.02.002_BIB27","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1164\/ajrccm.159.6.9808049","article-title":"Pneumonia acquired in the community through drug-resistant Streptococcus pneumoniae","volume":"159","author":"Ewig","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.lab.2004.02.002_BIB28","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1086\/313716","article-title":"Impact of penicillin susceptibility on medical outcomes for adult patients with bacteremic pneumococcal pneumonia","volume":"30","author":"Metlay","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.lab.2004.02.002_BIB29","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1086\/520209","article-title":"Penicillin resistance and other predictors of mortality in pneumococcal bacteremia in a population with high human immunodeficiency virus seroprevalence","volume":"29","author":"Turett","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.lab.2004.02.002_BIB30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/516284","article-title":"Pharmacokinetic\/pharmacodynamic parameters","volume":"26","author":"Craig","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.lab.2004.02.002_BIB31","first-page":"589","article-title":"Optimisation of antimicrobial therapy using pharmacokinetic and pharmacodynamic parameters","volume":"7","author":"Jacobs","year":"2001","journal-title":"CMI"},{"issue":"suppl 3","key":"10.1016\/j.lab.2004.02.002_BIB32","first-page":"38","article-title":"Relevance of pharmacokinetics and pharmacodynamics in the selection of antibiotics for respiratory tract infections","volume":"9","author":"Drusano","year":"1997","journal-title":"J Chemother"},{"key":"10.1016\/j.lab.2004.02.002_BIB33","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1378\/chest.112.6.1657","article-title":"Penicillin dosing for pneumococcal pneumonia","volume":"112","author":"Bryan","year":"1997","journal-title":"Chest"},{"key":"10.1016\/j.lab.2004.02.002_BIB34","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1086\/322623","article-title":"Clinical outcomes of bacteremic pneumococcal pneumonia in the era of antibiotic resistance","volume":"33","author":"Moroney","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.lab.2004.02.002_BIB35","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/00006454-200104000-00005","article-title":"Outcome of invasive infections outside the central nervous system caused by Streptococcus pneumoniae isolates nonsusceptible to ceftriaxone in children treated with beta-lactam antibiotics","volume":"20","author":"Kaplan","year":"2001","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.lab.2004.02.002_BIB36","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S0022-3476(98)70510-4","article-title":"Breakthrough bacteremia and meningitis during treatment with cephalosporins parenterally for pneumococcal pneumonia","volume":"132","author":"Buckingham","year":"1998","journal-title":"J Pediatr"},{"key":"10.1016\/j.lab.2004.02.002_BIB37","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1097\/00006454-199511000-00023","article-title":"Occurrence of Streptococcus penumoniae meningitis during vancomycin and cefotaxime therapy of septicemia in a patient with sick cell disease","volume":"14","author":"Chesney","year":"1995","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.lab.2004.02.002_BIB38","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1086\/588389","article-title":"Failure of treatment of pneumonia associated with highly resistant pneumococci in a child","volume":"29","author":"Dowell","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.lab.2004.02.002_BIB39","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1128\/AAC.40.5.1325","article-title":"Cefuroxime efficacy in treatment of bacteremic pneumonia due to penicillin-resistant and cefuroxime-resistant Streptococcus pneumoniae","volume":"40","author":"Caballero-Granado","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.lab.2004.02.002_BIB40","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1086\/377534","article-title":"An international prospective study of pneumococcal bacteremia","volume":"37","author":"Yu","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.lab.2004.02.002_BIB41","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1053\/rmed.2002.1358","article-title":"Cephalosporin-resistant pneumococcal pneumonia","volume":"96","author":"Ailani","year":"2002","journal-title":"Respir Med"},{"key":"10.1016\/j.lab.2004.02.002_BIB42","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1128\/AAC.46.9.2727-2734.2002","article-title":"Resistance to macrolides and related antibiotics in Streptococcus pneumoniae","volume":"46","author":"Leclercq","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.lab.2004.02.002_BIB43","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1001\/jama.286.15.1857","article-title":"Macrolide resistance among invasive Streptococcus pneumoniae isolates","volume":"286","author":"Hyde","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.lab.2004.02.002_BIB44","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1086\/318157","article-title":"Breakthrough pneumococcal bacteremia in patients being treated with azithromycin and clarithromycin","volume":"31","author":"Kelley","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.lab.2004.02.002_BIB45","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1056\/NEJM200202213460820","article-title":"Emergence of macrolide resistance during treatment of pneumococcal pneumonia","volume":"346","author":"Musher","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lab.2004.02.002_BIB46","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0732-8893(02)00379-6","article-title":"Azithromycin treatment failure in community-acquired pneumonia caused by Streptococcus pneumoniae resistant to macrolides by a 23S rRNA mutation","volume":"43","author":"Kays","year":"2002","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.lab.2004.02.002_BIB47","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1086\/341978","article-title":"Failure of macrolide antibiotic treatment in patients with bacteremia due to erythromycin-resistant Streptococcus pneumoniae","volume":"35","author":"Lonks","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.lab.2004.02.002_BIB48","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/jac\/dkg116","article-title":"Breakthrough pneumococcal bacteraemia in patients treated with clarithromycin or oral \u03b2-lactams","volume":"51","author":"van Kerkhoven","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.lab.2004.02.002_BIB49","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1086\/344965","article-title":"Macrolide-resistant pneumococcal endocarditis and epidural abscess that develop during erythromycin therapy","volume":"36","author":"Butler","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.lab.2004.02.002_BIB50","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0140-6736(67)92150-2","article-title":"Pneumococcus resistant to erythromycin and lincomycin","volume":"1","author":"Dixon","year":"1967","journal-title":"Lancet"},{"issue":"suppl 1","key":"10.1016\/j.lab.2004.02.002_BIB51","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1086\/324527","article-title":"Clinical relevance of macrolide-resistant Streptococcus pneumoniae for community-acquired pneumonia","volume":"34","author":"Lynch","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.lab.2004.02.002_BIB52","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1086\/313976","article-title":"Bacteremic pneumonia due to multidrug-resistant pneumococci in 3 patients treated unsuccessfully with azithromycin and successfully with levofloxacin","volume":"31","author":"Fogarty","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.lab.2004.02.002_BIB53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/44.1.1","article-title":"Pneumococcal macrolide resistance\u2014myth or reality?","volume":"44","author":"Amsden","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.lab.2004.02.002_BIB54","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/jac\/49.3.433","article-title":"The in vivo-in vitro paradox in pneumococcal respiratory tract infections","volume":"49","author":"Bishai","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.lab.2004.02.002_BIB55","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/jac\/45.3.401","article-title":"Pneumococcal macrolide resistance\u2014not a myth","volume":"45","author":"Perez-Trallero","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.lab.2004.02.002_BIB56","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1086\/341980","article-title":"In vivo veritas","volume":"35","author":"Jacobs","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.lab.2004.02.002_BIB57","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1086\/322735","article-title":"Macrolide-resistant Streptococcus pneumoniae and use of antimicrobial agents","volume":"33","author":"Pihlajamaki","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.lab.2004.02.002_BIB58","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1128\/AAC.43.5.1310","article-title":"Emergence of fluoroquinolone resistance among multiply resistant strains of Streptococcus pneumoniae in Hong Kong","volume":"43","author":"Ho","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.lab.2004.02.002_BIB59","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1128\/AAC.46.3.680-688.2002","article-title":"Fluoroquinolone resistance in Streptococcus pneumoniae in United States since 1994-1995","volume":"46","author":"Brueggemann","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.lab.2004.02.002_BIB60","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.1128\/AAC.46.10.3311-3315.2002","article-title":"Fluoroquinolone-resistant Streptococcus pneumoniae strains occur frequently in elderly patients in Japan","volume":"46","author":"Yokota","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.lab.2004.02.002_BIB61","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1086\/344768","article-title":"Widespread use of fluoroquinolones versus emerging resistance in pneumococci","volume":"35","author":"Goldstein","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.lab.2004.02.002_BIB62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3201\/eid0901.020277","article-title":"Maintaining fluoroquinolone class efficacy","volume":"9","author":"Scheld","year":"2003","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.lab.2004.02.002_BIB63","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1055\/s-2000-9927","article-title":"New antibiotics in pulmonary and critical care medicine","volume":"21","author":"Ambrose","year":"2000","journal-title":"Semin Resp Crit Care Med"},{"key":"10.1016\/j.lab.2004.02.002_BIB64","first-page":"115","article-title":"Moxifloxacins, a review of its clinical potential in the management of community-acquired respiratory tract infections","volume":"59","author":"Balfour","year":"2000","journal-title":"Drugs"},{"key":"10.1016\/j.lab.2004.02.002_BIB65","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1086\/319222","article-title":"Risk factors for acquisition of levofloxacin- resistant Streptococcus pneumoniae","volume":"32","author":"Ho","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.lab.2004.02.002_BIB66","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1592\/phco.22.5.395.33185","article-title":"Levofloxacin treatment failure in a patient with fluoroquinolone resistant Streptococcus pneumoniae pneumonia","volume":"22","author":"Kays","year":"2002","journal-title":"Pharamacotherapy"},{"key":"10.1016\/j.lab.2004.02.002_BIB67","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1056\/NEJMoa012122","article-title":"Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia","volume":"346","author":"Davidson","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lab.2004.02.002_BIB68","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1345\/aph.10229","article-title":"Levofloxacin failure in a patient with pneumococcal pneumonia","volume":"35","author":"Empey","year":"2001","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.lab.2004.02.002_BIB69","doi-asserted-by":"crossref","first-page":"312","DOI":"10.7326\/0003-4819-131-4-199908170-00023","article-title":"Fluoroquinolone resistance in Streptococcus pneumoniae","volume":"131","author":"Kuehnert","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.lab.2004.02.002_BIB70","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1086\/323086","article-title":"Fluoroquinolone-resistant Streptococcus pneumoniae associated with levofloxacin therapy","volume":"184","author":"Urban","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1016\/j.lab.2004.02.002_BIB71","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1086\/376642","article-title":"Emergence of levofloxacin-resistant pneumococci in immunocompromised adults after therapy for community-acquired pneumonia","volume":"37","author":"Anderson","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.lab.2004.02.002_BIB72","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1086\/377539","article-title":"High-dose, short-course levofloxacin for community-acquired pneumonia","volume":"37","author":"Dunbar","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.lab.2004.02.002_BIB73","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1097\/00007611-200295110-00013","article-title":"Pneumococcal susceptibility to meropenem in a mid-South children's hospital","volume":"11","author":"Buckingham","year":"2002","journal-title":"South Med J"},{"key":"10.1016\/j.lab.2004.02.002_BIB74","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.3201\/eid0909.020810","article-title":"Fluoroquinoione and macrolide treatment failure in pneumococcal pneumonia and selection of multidrug-resistant isolates","volume":"9","author":"Perez-Trallero","year":"2003","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.lab.2004.02.002_BIB75","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/S0025-7125(05)70385-0","article-title":"Streptococcus pneumoniae in community-acquired pneumonia. How important is drug resistance?","volume":"85","author":"Bauer","year":"2001","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.lab.2004.02.002_BIB76","doi-asserted-by":"crossref","unstructured":"Mufson MA, Stanek RJ. Bacteremic pneumococcal pneumonia in one American city: a 20-year longitudinal study, 1978-1997. Am J Med 1999;107(suppl 1A):34S-43S","DOI":"10.1016\/S0002-9343(99)00098-4"},{"key":"10.1016\/j.lab.2004.02.002_BIB77","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1001\/archinte.160.10.1399","article-title":"Management of community-acquired pneumonia in the era of pneumococcal resistance. A report from the Drug-resistant Streptococcus pneumoniae Therapeutic Working Group","volume":"160","author":"Heffelfinger","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.lab.2004.02.002_BIB78","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/00001432-200204000-00011","article-title":"Update on community-acquired pneumonia","volume":"15","author":"Metlay","year":"2002","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.lab.2004.02.002_BIB79","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1128\/AAC.44.6.1575-1577.2000","article-title":"Relationship between capsular type, penicillin susceptibility, and virulence of human Streptococcus pneumoniae isolates in mice","volume":"44","author":"Azoulay-Dupius","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.lab.2004.02.002_BIB80","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1086\/320992","article-title":"Complex relationship between acquisition of \u03b2-lactam resistance and loss of virulence in Streptococcus pneumoniae","volume":"184","author":"Rieux","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1016\/j.lab.2004.02.002_BIB81","first-page":"984","article-title":"Relationship between virulence and resistance to antimicrobials in pneumococci","volume":"39","author":"Bedos","year":"1991","journal-title":"Pathol Biol (Paris)"},{"key":"10.1016\/j.lab.2004.02.002_BIB82","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1128\/CMR.11.4.628","article-title":"Management of infections due to antibiotic-resistance Streptococcus pneumoniae","volume":"11","author":"Kaplan","year":"1998","journal-title":"Clin Microbiol Rev"},{"issue":"suppl 1","key":"10.1016\/j.lab.2004.02.002_BIB83","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1086\/324526","article-title":"Appropriate use of antimicrobials for drug-resistant pneumonia","volume":"34","author":"File","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"suppl 2","key":"10.1016\/j.lab.2004.02.002_BIB84","first-page":"69","article-title":"A critical assessment of published guidelines and other decision-support systems for the antibiotic treatment of community-acquired respiratory tract infections","volume":"8","author":"Finch","year":"2002","journal-title":"CMI"},{"issue":"suppl A","key":"10.1016\/j.lab.2004.02.002_BIB85","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/S0954-6111(01)90023-X","article-title":"Re-evaluating current antibiotic therapy","volume":"95","author":"Craig","year":"2001","journal-title":"Respir Med"},{"key":"10.1016\/j.lab.2004.02.002_BIB86","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1086\/367541","article-title":"Addition of a macrolide to a \u03b2-lactam\u2013based empirical antibiotic regimen is associated with lower in-hospital mortality for patients with bacteremic pneumococcal pneumonia","volume":"36","author":"Martinez","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.lab.2004.02.002_BIB87","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1001\/archinte.161.15.1837","article-title":"Monotherapy may be suboptimal for severe bacteremic pneumococcal pneumonia","volume":"161","author":"Waterer","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.lab.2004.02.002_BIB88","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1128\/AAC.47.3.1151-1153.2003","article-title":"Lack of synergy of erythromycin combined with penicillin or cefotaxime against Streptococcus pneumoniae in vitro","volume":"47","author":"Lin","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.lab.2004.02.002_BIB89","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1093\/jac\/46.6.973","article-title":"Antagonism between penicillin and erythromycin against Streptococcus pneumoniae in vitro and in vivo","volume":"46","author":"Johansen","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.lab.2004.02.002_BIB90","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1164\/ajrccm.163.7.at1010","article-title":"Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention","volume":"163","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.lab.2004.02.002_BIB91","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1086\/313954","article-title":"Practice guidelines for the management of community-acquired pneumonia in adults","volume":"31","author":"Bartlett","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.lab.2004.02.002_BIB92","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1086\/341900","article-title":"The battle against emerging antibiotic resistance","volume":"35","author":"Mandell","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.lab.2004.02.002_BIB93","doi-asserted-by":"crossref","first-page":"4357","DOI":"10.1128\/JCM.40.11.4357-4359.2002","article-title":"High rate of transmission of penicillin-resistant Streptococcus pneumoniae between parents and children","volume":"40","author":"Hoshino","year":"2002","journal-title":"J Clin Microbiol"}],"container-title":["Journal of Laboratory and Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022214304000344?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022214304000344?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T03:57:54Z","timestamp":1585799874000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022214304000344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5]]},"references-count":93,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004,5]]}},"alternative-id":["S0022214304000344"],"URL":"https:\/\/doi.org\/10.1016\/j.lab.2004.02.002","relation":{},"ISSN":["0022-2143"],"issn-type":[{"value":"0022-2143","type":"print"}],"subject":[],"published":{"date-parts":[[2004,5]]}}}